Navigation Links
Roche Scientist Recognized for Excellence in Peptide Chemistry
Date:10/7/2009

Danho joined Roche in 1980 following a well-established career as a noted peptide chemist. He earned his doctorate in 1967 at the prestigious RWTH University of Aachen in Germany where his research led to the first crystalline semi-synthetic insulin. Through his subsequent study of the pancreatic and pituitary hormones of camels, Danho helped discover that lipotropin is a pro-hormone of endorphin.

"I cannot think of anyone more deserving than Waleed to receive the Meienhofer Award," said Nader Fotouhi, Ph.D., Vice President for Discovery Chemistry at Roche in Nutley, New Jersey. Dr. Fotouhi noted that, "Waleed has built on the legacy that Dr. Meienhofer started at Roche and has taken it to a significantly higher level. His drive, enthusiasm, honesty, and experience have been critical to the revival of peptides as a therapeutic modality at Roche."

Applying his knowledge of peptides to his work at Roche, Danho fully dedicated himself to demonstrating the therapeutic potential of peptides and their proficiency as a biological proof of concept tool in drug discovery. Danho's research helped to prove that peptides can selectively interact with specific biologic targets to elicit particular effects. The results of his findings, which are documented in over 200 publications, 16 patents and myriad presentations, laid the groundwork for a number of potential new medicinal therapies, including a promising diabetes treatment.

The list of Danho's accomplishments while at Roche is long, but among the most significant achievements is the investigation of cholecystokinin involvement as a systematic approach to discovering peptide mimetics and enriching the Roche intellectual portfolio on peptide nucleic acids (PNAs). However, he is probably best recognized for his seminal work in male erectile dysfunction (ED). While originally evaluating metanocortin-4 (MC-4) receptor antagonist in the treatment of obesity, Danho's research group recogniz
'/>"/>

SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
2. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
3. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
4. Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)
5. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
6. Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
7. National Jewish Health and Roche Diagnostics Corporation Reach Agreement to Pursue Environmental Molecular Diagnostics Opportunities
8. MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis
9. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
10. Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
11. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...0 Reportlinker.com announces that ...atalogue. ,, Medical Adhesives and Sealants - ...r.com/p0164242/Medical-Adhesives-and-Sealants---A-...m_medium=pr&utm_campaign=prnewswire ,, Th... preeminence in medical devices and equipments. Cu...
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq:... and Chief Executive Officer, and Greg Browne, Chi...ual Piper Jaffray Health Care Conference in New Yo... The conference session and webcast will be audio...er Jaffray will host a webcast of the presentation...
(Date:11/20/2009)... 20 Smith & Nephew (... announce the signing of a technology development ...nse that may lead to the creation of a fracture fi...ent of the limbs of soldiers who sustain battlefie... Research Projects Agency (DARPA), the central res...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 476 Children Dead From Swine Flu 3A CDC 59232 176 Children Dead From Swine Flu 3A CDC 59232 276 Children Dead From Swine Flu 3A CDC 59232 3American Heart Association Guidelines Save Lives 59228 1American Heart Association Guidelines Save Lives 59228 2Amended Chairmans Mark Sets Stage for 26quot 3BHitting Bulls eye in Health Reform 26quot 3B 59224 1Amended Chairmans Mark Sets Stage for 26quot 3BHitting Bulls eye in Health Reform 26quot 3B 59224 2
...ial for Cervical Dysplasia to Begin Mid-2008 -, S...oration (TSX: NVN) today announced the completion ...ourth and final cohort of patients in its,Phase 1 ...idate, in women,with cervical intraepithelial neop...y review demonstrated that HspE7 was safe and well...
...O, April 24 Elekta, a global leader,in minimally ... of,stereotactic solutions at the 76th Annual Meet...rgeons, (AANS), April 26 - May 1 in Chicago,Illino...exion(TM) and,Elekta Axesse(TM), two stereotactic ...ities for the most challenging cases., Now in cli...
Other Medicine Technology:Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial 5Elekta's New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time 2
(Date:11/20/2009)..., Nov. 20 SIRIUS XM Rad...broadcast Doctor Radio Reports: What Every Wome...cial hosted by veteran journalist Perri Peltz. ,...080819/NYTU044LOGO ) ,, Doctor Radio Reports... will air November 21 live at 10:00 am ET on Doc...
(Date:11/20/2009)...November 20, 2009Emergency medical service (EMS) p...350,000 cardiac arrests each year. Only 5 to 10 p...rvive. Better quality cardiopulmonary resuscitati... be associated with better patient outcome. The R...est clinical research network to study prehospital...
(Date:11/20/2009)...e severe cases than with seasonal flu , ...searchers are reporting that children with asthma ...u than seasonal flu. , "Asthma has been identif...h pandemic H1N1 influenza, present in 21 percent t...on Allen and fellow researchers from the Hospital ...
(Date:11/20/2009)...Mo., Nov. 20 Missouri state employ...gions will now have the option to choose Mercy Hea...etween Missouri Consolidated Health Care Plan (MCH...d South Central Missouri regions include the follo...de, Dallas, Douglas, Greene, Hickory, Howell, Jasp...
(Date:11/20/2009)...ov. 20 Today, iconic denim brand ...e the launch of a capsule gift giving collection o...day season. This collection is inspired by and de...,s Thanks and Giving® Program, a holiday fu...onsumers to "give thanks for the healthy kids in y...
Breaking Medicine News(10 mins):Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3
...mmitment to industry best practices, meets new ...INNEAPOLIS, Aug. 21 National health care consulti...the development of a,comprehensive accreditation p...ion Commission (URAC)., The URAC assistance progr...
... 2008 Inc. 5,000 list, experiences three-year ...RTLAND, Ore., Aug. 21 Inc. recently unveiled Vigi... fastest-growing private,companies in the United S...igilan delivers operational management software to...
...The Pancreatic Cancer,Action Network ( http://www....ing hope in a comprehensive way through research, ...r a cure, is saddened by the loss of NFL,Hall of F...Fleshman, President,and CEO. "I know personally th...
...youngsters, so sex ed should be added to lineup, s...y News) -- One reason why abstinence-only programs...because abstinence can mean different things to te...titudes and intentions about being abstinent, the ...
...w names and fresh website highlight stronger focus...ftware , Vancouver, BC (P... provider of healthcare education administration s...tion products., , ,CompleteM.E. and FacultyTrack r...
...Association of,International Automobile Manufactur...esearch initiative conducted by the Children,s Hos...port for the largest source of,data on children in...mproved federal motor vehicle safety standards,pub...
Other Medicine News:Health News:Halleland Health Consulting Establishes URAC Accreditation Program 2Health News:Vigilan Recognized as One of the Fastest-Growing Private Companies in the U.S. 2Health News:The Pancreatic Cancer Action Network is Saddened by the Death of NFL Hall of Fame Member Gene Upshaw 2Health News:Abstinence-Only Programs Fall Short of Teens' Needs 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:AIAM Sponsors Leading Child Safety Research Initiative 2
HDL-C Immuno FS
HDL Cholesterol (PEG)
HDL Cholesterol Reagent
HDL Cholesterol
Medicine Products: